Issues and Initiatives (Other Areas)

Procurement, Production and Logistics

Issues

As a global pharmaceutical company, Takeda procures materials needed to make its products from around the world, including in emerging markets. We realize that respecting human rights, including the rights of workers, is one of our greatest responsibilities with regard to procurement activities. To meet this obligation, we require our suppliers to pay sufficient attention to human rights.
In our production activities, we are also committed to fulfilling our responsibility regarding the health of people who live near our factories. In logistics, meanwhile, we view counterfeit drugs as one of our most pressing issues throughout the entire flow from procurement to production and distribution.

Initiatives

Takeda is strengthening its initiatives to respond to issues across the entire value chain through the establishment of the "Guidelines for Socially Responsible Purchasing" and the formulation of its own standards for conduct in 2010. In addition, we are communicating with our suppliers, telling them clearly what we expect of them and providing them with a code of conduct.
To reduce exposure to environmental risks, we established the Takeda Pharmaceutical Environmental Action Plan and are making steady progress with associated activities. We are also conducting programs on a global scale to prevent the sale of counterfeit drugs.

Sales

Issues

Since pharmaceutical products are vital to maintaining health, their improper use can create problems for patients as well as society as a whole. Takeda considers it a fundamental obligation to prevent such problems. Our duty is to supply high-quality products while employing suitable methods to provide, collect and convey drug information in an accurate and speedy manner.

Initiatives

Takeda works hard to ensure that its promotion activities are fair. We comply with two relevant guidelines established within the Japanese pharmaceutical industry: the Promotion Code for Prescription Drugs and the Fair Competition Code for Ethical Drug Production and Sales, and have also established our own Transparency Guideline for the Relation between Corporate Activities and Medical Institutions. Takeda has its own promotion code and rules as well. These rules provide a framework for high-quality activities providing information on medicines based on high ethical standards along with respect for the human rights of patients.

Takeda participates in the human rights working groups of BSR, which is an international body of corporate members concerned with CSR, and the Global Compact Japan Network.